These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35204463)

  • 21. Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.
    Broniscer A; Hwang SN; Chamdine O; Lin T; Pounds S; Onar-Thomas A; Chi L; Shurtleff S; Allen S; Gajjar A; Northcott P; Orr BA
    Brain Pathol; 2018 Jan; 28(1):112-120. PubMed ID: 28032389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.
    Paugh BS; Qu C; Jones C; Liu Z; Adamowicz-Brice M; Zhang J; Bax DA; Coyle B; Barrow J; Hargrave D; Lowe J; Gajjar A; Zhao W; Broniscer A; Ellison DW; Grundy RG; Baker SJ
    J Clin Oncol; 2010 Jun; 28(18):3061-8. PubMed ID: 20479398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence
    Fu Y; Li Z; Gao F; Yang J; Wu H; Zhang B; Pu X; Fan X
    Front Oncol; 2021; 11():669197. PubMed ID: 33996597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
    Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
    Benesch M; Wagner S; Berthold F; Wolff JE
    J Neurooncol; 2005 Apr; 72(2):179-83. PubMed ID: 15925999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outcomes of concomitant chemoradiotherapy followed by adjuvant chemotherapy with temozolomide for newly diagnosed high grade gliomas : the preliminary results of single center prospective study.
    Choi JW; Lee MM; Kim IA; Kim JH; Choe G; Kim CY
    J Korean Neurosurg Soc; 2008 Oct; 44(4):222-7. PubMed ID: 19096681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
    J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas.
    Passariello A; Errico ME; Donofrio V; Maestrini M; Zerbato A; Cerchia L; Capasso M; Capasso M; Fedele M
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan.
    Sirachainan N; Boongird A; Swangsilpa T; Klaisuban W; Lusawat A; Hongeng S
    Childs Nerv Syst; 2017 Jun; 33(6):893-897. PubMed ID: 28439659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
    Ziegler DS; Wong M; Mayoh C; Kumar A; Tsoli M; Mould E; Tyrrell V; Khuong-Quang DA; Pinese M; Gayevskiy V; Cohn RJ; Lau LMS; Reynolds M; Cox MC; Gifford A; Rodriguez M; Cowley MJ; Ekert PG; Marshall GM; Haber M
    Br J Cancer; 2018 Sep; 119(6):693-696. PubMed ID: 30220707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
    Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput microRNA profiling of pediatric high-grade gliomas.
    Miele E; Buttarelli FR; Arcella A; Begalli F; Garg N; Silvano M; Po A; Baldi C; Carissimo G; Antonelli M; Spinelli GP; Capalbo C; Donofrio V; Morra I; Nozza P; Gulino A; Giangaspero F; Ferretti E
    Neuro Oncol; 2014 Jan; 16(2):228-40. PubMed ID: 24305714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.
    Paugh BS; Zhu X; Qu C; Endersby R; Diaz AK; Zhang J; Bax DA; Carvalho D; Reis RM; Onar-Thomas A; Broniscer A; Wetmore C; Zhang J; Jones C; Ellison DW; Baker SJ
    Cancer Res; 2013 Oct; 73(20):6219-29. PubMed ID: 23970477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers.
    Carter-Febres M; Schneller N; Fair D; Solomon D; Perry A; Roy A; Linscott L; Alashari M; Kestle JR; Bruggers CS
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e987-e990. PubMed ID: 33093355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.